All About,Inc. Logo

All About,Inc.

Japanese digital media group connecting businesses and consumers via e-commerce and product sampling.

2454 | T

Overview

Corporate Details

ISIN(s):
JP3174050009
LEI:
Country:
Japan
Address:
渋谷区恵比寿南1丁目15番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

All About, Inc. is a Japanese digital media and marketing group. Through its subsidiary, All About Life Marketing, the company operates "Sample Hyakkaten," one of Japan's largest product trial and e-commerce platforms, enabling consumers to test products. The group's activities also include conducting and publishing consumer market research, hosting promotional events like the "Real Sampling Lab," and expanding its portfolio through strategic acquisitions and service integrations. The company focuses on connecting businesses and consumers through its various marketing, e-commerce, and media services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-26 06:00
Regulatory News Service
臨時報告書
Japanese 26.9 KB
2025-06-24 08:59
Registration Form
確認書
Japanese 8.8 KB
2025-06-24 08:59
Governance Information
内部統制報告書-第33期(2024/04/01-2025/03/31)
Japanese 23.1 KB
2025-06-24 08:56
Annual Report
有価証券報告書-第33期(2024/04/01-2025/03/31)
Japanese 1.2 MB
2025-03-27 08:35
Regulatory News Service
臨時報告書
Japanese 20.3 KB
2024-11-13 08:37
Regulatory News Service
確認書
Japanese 8.7 KB
2024-11-13 08:36
Interim Report
半期報告書-第33期(2024/04/01-2025/03/31)
Japanese 214.4 KB
2024-06-26 07:54
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2024-06-26 07:53
Registration Form
確認書
Japanese 8.8 KB
2024-06-26 07:52
Governance Information
内部統制報告書-第32期(2023/04/01-2024/03/31)
Japanese 23.4 KB
2024-06-26 07:51
Annual Report
有価証券報告書-第32期(2023/04/01-2024/03/31)
Japanese 1.1 MB
2024-04-03 06:49
Regulatory News Service
臨時報告書
Japanese 20.7 KB
2024-02-09 07:24
Report Publication Announcement
確認書
Japanese 8.9 KB
2024-02-09 07:05
Quarterly Report
四半期報告書-第32期第3四半期(2023/10/01-2023/12/31)
Japanese 180.3 KB
2023-11-10 07:59
Report Publication Announcement
確認書
Japanese 8.8 KB

Automate Your Workflow. Get a real-time feed of all All About,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for All About,Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for All About,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Celyad Oncology SA Logo
Clinical-stage biotech developing CAR T therapies for solid and blood cancers.
Belgium CYAD
CENTAUR MEDIA PLC Logo
Provides business intelligence, learning, and consultancy for marketing & legal professionals.
United Kingdom CAU
Cereno Scientific AB Logo
Develops epigenetic therapies for rare cardiovascular and pulmonary diseases.
Sweden CRNO
CERES INC. Logo
Develops online media platforms connecting consumers with advertisers through a rewards system.
Japan 3696
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and offers CDMO, biobanking, and genomics services for rare diseases.
South Korea 085660
An Ad-Tech firm providing digital marketing, SEO, social media, and creative ad solutions.
South Korea 351870
Ch. Charilaou Group Plc Logo
A tour operator selling travel packages and developing online reservation platform solutions.
Cyprus CHCH
Creates data-driven, integrated marketing and connected experiences for global brands.
South Korea 030000
Chiome Bioscience Inc. Logo
Clinical-stage biotech developing therapeutic antibodies and providing R&D services to partners.
Japan 4583
Chordia Therapeutics,Inc Logo
Developing first-in-class, small-molecule anti-cancer drugs targeting RNA deregulation.
Japan 190A

Talk to a Data Expert

Have a question? We'll get back to you promptly.